FDA-Inspected Site

Bistos Co Ltd

2 FDA inspections are on record for Bistos Co Ltd in Seongnam-Si, Gyeonggi-Do, Korea (the Republic of).

Clean· No action indicated

Seongnam-Si, Gyeonggi-Do, Korea (the Republic of) · Last updated July 11, 2026

Overview

  • 2 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2019-11-07.

At a glance

Inspections

2

Form 483s

1

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
4 Nov 2019 – 7 Nov 2019Medical Devices & Rad HealthClean
27 Sep 2012Not recorded483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

27 Sep 2012
21 CFR 820.30(f)

Design verification - Lack of or inadequate procedures

Cited by Christine M Parmentier

27 Sep 2012
21 CFR 820.70(a)

Process control procedures, Lack of or inadequate procedures

Cited by Christine M Parmentier

27 Sep 2012
21 CFR 820.70(i)

Documentation of software validation

Cited by Christine M Parmentier

27 Sep 2012
21 CFR 820.100(b)

Documentation

Cited by Christine M Parmentier

27 Sep 2012
21 CFR 820.198(a)

Lack of or inadequate complaint procedures

Cited by Christine M Parmentier

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 820.100(b)Cited across public-safe Form 483 observations1x
21 CFR 820.198(a)Cited across public-safe Form 483 observations1x
21 CFR 820.30(f)Cited across public-safe Form 483 observations1x
21 CFR 820.70(a)Cited across public-safe Form 483 observations1x
21 CFR 820.70(i)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Bistos Co Ltd's 1 Form 483

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat